| Kendra Denise Deangelis, MD | |
|
2963 Gulf To Bay Blvd Ste 267, Clearwater, FL 33759-4209 | |
| (787) 285-8006 | |
| (727) 216-6560 |
| Full Name | Kendra Denise Deangelis |
|---|---|
| Gender | Female |
| Speciality | Ophthalmology |
| Experience | 13 Years |
| Location | 2963 Gulf To Bay Blvd Ste 267, Clearwater, Florida |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043506595 | NPI | - | NPPES |
| DUPRY | Other | BCBS GROUP | |
| LWBRR | Other | FL | BCBS |
| 13809966 | Other | FL | CAQH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207WX0200X | Ophthalmology - Ophthalmic Plastic And Reconstructive Surgery | ME136932 (Florida) | Secondary |
| 207W00000X | Ophthalmology | ME136932 (Florida) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Morton Plant Hospital | Clearwater, FL | Hospital |
| Entity Name | Mohadjer Consulting Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831735224 PECOS PAC ID: 1850728148 Enrollment ID: O20200226001624 |
News Archive
Today's FDA approval of the monoclonal antibody Aduhelm (aducanumab) to treat patients with Alzheimer's disease reflects years of significant advances in Alzheimer's research. This is the first new Alzheimer's drug approved in 17 years and the first shown to modify the course of the disease, which FDA believes will lead to slowing of patients' cognitive decline.
Nikki Posnack, Ph.D., a post-doctoral pharmacology and physiology researcher at the George Washington University School of Medicine and Health Sciences (SMHS), received a $209,926 grant from the National Institute of Environmental Health Sciences to study plastics and their potential human health risks, particularly in the cardiovascular system.
A team of investigators headed by International AIDS Vaccine Initiative Investigator Pascal Poignard has been awarded a major grant from the National Institute of Allergy and Infectious Diseases of the US National Institutes of Health to investigate the biological mechanisms underlying the generation of broadly neutralizing antibodies by HIV positive individuals.
Insurance status doesn't affect the quantity (or value) of imaging services received by patients in a hospital, in-patient setting, according to a study in the January issue of the Journal of the American College of Radiology.
Sosei Group Corporation, the biopharmaceutical company, today announced that Sosei Co., Ltd., its wholly owned Japanese subsidiary, was granted approval for its emergency contraceptive pill, NorLevo(R) TABLETS 0.75mg, by the Japan Ministry of Health, Labour and Welfare (MHLW). NorLevo(R) has thus become the fist emergency contraceptive pill available in Japan.
› Verified 3 days ago
| Entity Name | Tampa Bay Ophthalmic Plastics Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1811511207 PECOS PAC ID: 4789000886 Enrollment ID: O20200820000035 |
News Archive
Today's FDA approval of the monoclonal antibody Aduhelm (aducanumab) to treat patients with Alzheimer's disease reflects years of significant advances in Alzheimer's research. This is the first new Alzheimer's drug approved in 17 years and the first shown to modify the course of the disease, which FDA believes will lead to slowing of patients' cognitive decline.
Nikki Posnack, Ph.D., a post-doctoral pharmacology and physiology researcher at the George Washington University School of Medicine and Health Sciences (SMHS), received a $209,926 grant from the National Institute of Environmental Health Sciences to study plastics and their potential human health risks, particularly in the cardiovascular system.
A team of investigators headed by International AIDS Vaccine Initiative Investigator Pascal Poignard has been awarded a major grant from the National Institute of Allergy and Infectious Diseases of the US National Institutes of Health to investigate the biological mechanisms underlying the generation of broadly neutralizing antibodies by HIV positive individuals.
Insurance status doesn't affect the quantity (or value) of imaging services received by patients in a hospital, in-patient setting, according to a study in the January issue of the Journal of the American College of Radiology.
Sosei Group Corporation, the biopharmaceutical company, today announced that Sosei Co., Ltd., its wholly owned Japanese subsidiary, was granted approval for its emergency contraceptive pill, NorLevo(R) TABLETS 0.75mg, by the Japan Ministry of Health, Labour and Welfare (MHLW). NorLevo(R) has thus become the fist emergency contraceptive pill available in Japan.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kendra Denise Deangelis, MD Po Box 917770, Orlando, FL 32891-0001 Ph: () - | Kendra Denise Deangelis, MD 2963 Gulf To Bay Blvd Ste 267, Clearwater, FL 33759-4209 Ph: (787) 285-8006 |
News Archive
Today's FDA approval of the monoclonal antibody Aduhelm (aducanumab) to treat patients with Alzheimer's disease reflects years of significant advances in Alzheimer's research. This is the first new Alzheimer's drug approved in 17 years and the first shown to modify the course of the disease, which FDA believes will lead to slowing of patients' cognitive decline.
Nikki Posnack, Ph.D., a post-doctoral pharmacology and physiology researcher at the George Washington University School of Medicine and Health Sciences (SMHS), received a $209,926 grant from the National Institute of Environmental Health Sciences to study plastics and their potential human health risks, particularly in the cardiovascular system.
A team of investigators headed by International AIDS Vaccine Initiative Investigator Pascal Poignard has been awarded a major grant from the National Institute of Allergy and Infectious Diseases of the US National Institutes of Health to investigate the biological mechanisms underlying the generation of broadly neutralizing antibodies by HIV positive individuals.
Insurance status doesn't affect the quantity (or value) of imaging services received by patients in a hospital, in-patient setting, according to a study in the January issue of the Journal of the American College of Radiology.
Sosei Group Corporation, the biopharmaceutical company, today announced that Sosei Co., Ltd., its wholly owned Japanese subsidiary, was granted approval for its emergency contraceptive pill, NorLevo(R) TABLETS 0.75mg, by the Japan Ministry of Health, Labour and Welfare (MHLW). NorLevo(R) has thus become the fist emergency contraceptive pill available in Japan.
› Verified 3 days ago
Mr. Dana M Deupree, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3280 N Mcmullen Booth Rd, Suite 120, Clearwater, FL 33761 Phone: 727-789-8770 Fax: 727-789-8784 | |
Steven Myles Cohen, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 579 S Duncan Ave, Clearwater, FL 33756 Phone: 727-445-9110 Fax: 727-466-0306 | |
Samantha Nastasi, Ophthalmology Medicare: Medicare Enrolled Practice Location: 601 S Belcher Rd, Clearwater, FL 33764 Phone: 727-266-2393 Fax: 727-266-2330 | |
Dr. Scott Behler, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2346 Drew St, Clearwater, FL 33765 Phone: 727-712-2500 Fax: 727-712-2511 | |
Dr. Selina Jia-hwa Lin, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3001 Eastland Blvd Ste 1, Clearwater, FL 33761 Phone: 833-733-3754 | |
Mr. Herbert P Knauf Iii, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2560 Gulf To Bay Blvd, Suite 100, Clearwater, FL 33765 Phone: 727-799-3772 Fax: 727-791-6598 |